NYSE:INSP Inspire Medical Systems (INSP) Stock Price, News & Analysis → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free INSP Stock Alerts $229.03 -12.12 (-5.03%) (As of 02:51 PM ET) Add Compare Share Share Today's Range$228.66▼$244.6550-Day Range$177.50▼$243.5152-Week Range$123.27▼$330.00Volume295,503 shsAverage Volume533,179 shsMarket Capitalization$6.94 billionP/E RatioN/ADividend YieldN/APrice Target$272.20 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Inspire Medical Systems alerts: Email Address Inspire Medical Systems MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.71 Rating ScoreUpside/Downside16.3% Upside$272.20 Price TargetShort InterestBearish6.86% of Shares Sold ShortDividend StrengthN/ASustainability-0.66Upright™ Environmental ScoreNews Sentiment0.99Based on 18 Articles This WeekInsider TradingSelling Shares$15.66 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.35) to $0.58 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.01 out of 5 starsMedical Sector281st out of 918 stocksSurgical & Medical Instruments Industry34th out of 97 stocks 3.4 Analyst's Opinion Consensus RatingInspire Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 10 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageInspire Medical Systems has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted6.86% of the outstanding shares of Inspire Medical Systems have been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Inspire Medical Systems has recently increased by 11.23%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldInspire Medical Systems does not currently pay a dividend.Dividend GrowthInspire Medical Systems does not have a long track record of dividend growth. Previous Next 4.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreInspire Medical Systems has received a 78.27% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Neurostimulators" and "Medical technology engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Inspire Medical Systems is -0.66. Previous Next 3.3 News and Social Media Coverage News SentimentInspire Medical Systems has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Inspire Medical Systems this week, compared to 7 articles on an average week.Search Interest12 people have searched for INSP on MarketBeat in the last 30 days. This is an increase of 71% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,664,278.00 in company stock.Percentage Held by InsidersOnly 4.10% of the stock of Inspire Medical Systems is held by insiders.Percentage Held by Institutions94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Inspire Medical Systems are expected to grow in the coming year, from ($0.35) to $0.58 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inspire Medical Systems is -316.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inspire Medical Systems is -316.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInspire Medical Systems has a P/B Ratio of 12.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad DarwinYour Next Portfolio Star: Revealing 2024's Top Stock Pick We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)Click here to download your report About Inspire Medical Systems Stock (NYSE:INSP)Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.Read More INSP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INSP Stock News HeadlinesApril 19, 2024 | insidertrades.comInspire Medical Systems, Inc. (NYSE:INSP) CFO Sells $3,450,450.00 in StockApril 4, 2024 | insidertrades.comInspire Medical Systems, Inc. (NYSE:INSP) CEO Sells $8,203,600.00 in StockApril 19, 2024 | Darwin (Ad)Explore the Future: Unlock the Top 3 AI Stocks for 2024 ReportEager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)March 28, 2024 | insidertrades.comJerry C. Griffin Sells 554 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) StockMarch 27, 2024 | insidertrades.comInspire Medical Systems, Inc. (NYSE:INSP) CTO Sells $852,832.80 in StockMarch 21, 2024 | insidertrades.comInspire Medical Systems, Inc. (NYSE:INSP) Director Sells $107,215.62 in StockApril 19, 2024 | americanbankingnews.comFinancial Review: Inspire Medical Systems (NYSE:INSP) versus Co-Diagnostics (NASDAQ:CODX)April 17, 2024 | markets.businessinsider.comPositive SURMOUNT-OSA Trial Results Reinforce Buy Rating for Inspire Medical SystemsApril 19, 2024 | DTI (Ad)Start loving Mondays like thisWouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!April 17, 2024 | msn.comInspire Medical rebounds as J.P. Morgan defends after Lilly sleep dataApril 17, 2024 | msn.comBest selling female perfumes to inspire your new signature scentApril 17, 2024 | msn.comHere's Why You Should Retain Henry Schein (HSIC) Stock for NowApril 17, 2024 | finance.yahoo.comRecent 7.0% pullback isn't enough to hurt long-term Inspire Medical Systems (NYSE:INSP) shareholders, they're still up 353% over 5 yearsApril 15, 2024 | msn.comMedical Resident Shares One Symptom That Led to Her Metastatic Sarcoma Diagnosis — Now She Inspires Others (Exclusive)April 15, 2024 | americanbankingnews.comInspire Medical Systems, Inc. (NYSE:INSP) Short Interest Up 11.2% in MarchApril 14, 2024 | americanbankingnews.comInspire Medical Systems, Inc. (NYSE:INSP) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesApril 10, 2024 | msn.comIs Intuitive Surgical Stock Going to $430? 1 Wall Street Analyst Thinks So.April 5, 2024 | investing.comInspire Medical Systems director sells shares worth over $6.8kApril 4, 2024 | msn.comHow stress can harm your health — and what to do about itApril 4, 2024 | msn.comBaird puts Inspire on top idea list, sees limited impact by GLP-1sApril 3, 2024 | msn.comLee Health: Making an impact – Community benefit report showcases our efforts, commitmentApril 2, 2024 | msn.com10 shows that aren’t worth the hypeApril 2, 2024 | msn.comMinnesota school district seeks to hire $100-200k 'anti-racist' official who can examine 'Whiteness’April 2, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Tandem Diabetes Care (TNDM), Apyx Medical (APYX)April 2, 2024 | finance.yahoo.comInspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024April 2, 2024 | globenewswire.comInspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024April 2, 2024 | msn.comMid-Michigan doctor rips the band-aid off the problems with American medicineSee More Headlines Receive INSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/06/2024Today4/19/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:INSP CUSIPN/A CIK1609550 Webwww.inspiresleep.com Phone(844) 672-4357FaxN/AEmployees1,011Year FoundedN/APrice Target and Rating Average Stock Price Target$271.29 High Stock Price Target$371.00 Low Stock Price Target$159.00 Potential Upside/Downside+12.5%Consensus RatingModerate Buy Rating Score (0-4)2.69 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)($0.74) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-21,150,000.00 Net Margins-3.39% Pretax Margin-3.19% Return on Equity-3.93% Return on Assets-3.38% Debt Debt-to-Equity RatioN/A Current Ratio7.60 Quick Ratio7.17 Sales & Book Value Annual Sales$624.80 million Price / Sales11.69 Cash FlowN/A Price / Cash FlowN/A Book Value$19.39 per share Price / Book12.44Miscellaneous Outstanding Shares30,300,000Free Float29,055,000Market Cap$7.31 billion OptionableOptionable Beta1.37 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Timothy P. Herbert (Age 61)CEO, President & Director Comp: $1.36MMr. Richard J. Buchholz (Age 56)Chief Financial Officer Comp: $663.43kMr. Philip J. Ebeling (Age 53)Chief Operating Officer Comp: $675.41kMr. Randall A. Ban (Age 59)Chief Commercial Officer Comp: $624.45kDr. Charisse Y. Sparks FAAOS (Age 61)M.D., Chief Medical Officer Comp: $31.35kMr. Carlton W. Weatherby (Age 39)Chief Strategy Officer Comp: $553.29kMr. John C. Rondoni (Age 44)Chief Technology Officer Comp: $576.72kMs. Ezgi YagciVice President of Investor RelationsMr. Bryan K. Phillips (Age 53)Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary Comp: $639.9kMr. Steven L. Jandrich (Age 57)Vice President of Human Resources Comp: $417.22kMore ExecutivesKey CompetitorsGlobus MedicalNYSE:GMEDPenumbraNYSE:PENGlaukosNYSE:GKOSHaemoneticsNYSE:HAEMerit Medical SystemsNASDAQ:MMSIView All CompetitorsInsiders & InstitutionsWasatch Advisors LPBought 5,522 shares on 4/18/2024Ownership: 3.640%Allspring Global Investments Holdings LLCSold 53,245 shares on 4/18/2024Ownership: 0.550%Diversified Trust CoBought 1,150 shares on 4/18/2024Ownership: 0.018%Oak Thistle LLCSold 852 shares on 4/18/2024Ownership: 0.005%Richard BuchholzSold 15,000 sharesTotal: $3.45 M ($230.03/share)View All Insider TransactionsView All Institutional Transactions INSP Stock Analysis - Frequently Asked Questions Should I buy or sell Inspire Medical Systems stock right now? 14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" INSP shares. View INSP analyst ratings or view top-rated stocks. What is Inspire Medical Systems' stock price target for 2024? 14 brokerages have issued 12-month price targets for Inspire Medical Systems' shares. Their INSP share price targets range from $159.00 to $371.00. On average, they predict the company's share price to reach $272.20 in the next year. This suggests a possible upside of 16.3% from the stock's current price. View analysts price targets for INSP or view top-rated stocks among Wall Street analysts. How have INSP shares performed in 2024? Inspire Medical Systems' stock was trading at $203.43 at the beginning of 2024. Since then, INSP stock has increased by 15.1% and is now trading at $234.07. View the best growth stocks for 2024 here. Are investors shorting Inspire Medical Systems? Inspire Medical Systems saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,080,000 shares, an increase of 11.2% from the March 15th total of 1,870,000 shares. Based on an average daily volume of 488,200 shares, the days-to-cover ratio is currently 4.3 days. View Inspire Medical Systems' Short Interest. When is Inspire Medical Systems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our INSP earnings forecast. How can I listen to Inspire Medical Systems' earnings call? Inspire Medical Systems will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link. How were Inspire Medical Systems' earnings last quarter? Inspire Medical Systems, Inc. (NYSE:INSP) released its quarterly earnings data on Tuesday, February, 6th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.53. The business earned $192.51 million during the quarter, compared to analysts' expectations of $186.75 million. Inspire Medical Systems had a negative trailing twelve-month return on equity of 3.93% and a negative net margin of 3.39%. The firm's revenue for the quarter was up 39.6% compared to the same quarter last year. During the same period last year, the business earned $0.10 EPS. What ETFs hold Inspire Medical Systems' stock? ETFs with the largest weight of Inspire Medical Systems (NYSE:INSP) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Harbor Health Care ETF (MEDI), Fidelity Digital Health ETF (FDHT), Fidelity Disruptive Medicine ETF (FMED), BNY Mellon Innovators ETF (BKIV), Principal Healthcare Innovators ETF (BTEC), SPDR S&P Health Care Equipment ETF (XHE) and WisdomTree U.S. Growth & Momentum Fund (WGRO). What guidance has Inspire Medical Systems issued on next quarter's earnings? Inspire Medical Systems updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $775.0 million-$785.0 million, compared to the consensus revenue estimate of $780.3 million. What is Tim Herbert's approval rating as Inspire Medical Systems' CEO? 2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Inspire Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ). When did Inspire Medical Systems IPO? Inspire Medical Systems (INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers. Who are Inspire Medical Systems' major shareholders? Inspire Medical Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Wasatch Advisors LP (3.64%), Allspring Global Investments Holdings LLC (0.55%), Rheos Capital Works Inc. (0.26%), Congress Asset Management Co. MA (0.05%), Massmutual Trust Co. FSB ADV (0.05%) and Private Ocean LLC (0.04%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View institutional ownership trends. How do I buy shares of Inspire Medical Systems? Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:INSP) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 MediaMy biggest AI fearParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.